Molecular Hydrogen Therapy for SLE-PAH: Case Report on Immune Marker Modulation.

In Vivo · 2025 · PMC11884449 · PMID 40010970

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Following the administration of molecular hydrogen therapy, a decreasing trend in B cell subset percentages was observed, suggesting that this therapy has the potential to modulate B cell function.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.